1,2-dipalmitoylphosphatidylglycerol and Cancer of Prostate

1,2-dipalmitoylphosphatidylglycerol has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, L; Quan, D; Wang, T; Zhang, G	1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and Cancer of Prostate

Article	Year
Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment. International journal of pharmaceutics, 2013, Jun-25, Volume: 450, Issue:1-2 Topics: Administration, Oral; Animals; Castor Oil; Castration; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Oligopeptides; Pancreatin; Pepsin A; Phosphatidylcholines; Phosphatidylglycerols; Propylene Glycol; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone	2013

Article

Year

Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.

International journal of pharmaceutics, 2013, Jun-25, Volume: 450, Issue:1-2

Topics: Administration, Oral; Animals; Castor Oil; Castration; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Oligopeptides; Pancreatin; Pepsin A; Phosphatidylcholines; Phosphatidylglycerols; Propylene Glycol; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone

2013